The Successful Use of Nitroglycerin for Uterine Hyperstimulation with Fetal Heart Rate Abnormality Caused by a Controlled-Release Dinoprostone Vaginal Delivery System (PROPESS): A Case Report

Medicina (Kaunas). 2021 May 12;57(5):478. doi: 10.3390/medicina57050478.

Abstract

The PROPESS, a controlled-release dinoprostone vaginal delivery system, is a pharmacological cervical ripening intervention and promotes cervical change causing uterine contraction. During insertion of the PROPESS, uterine hyperstimulation could occur and result in fetal heart rate (FHR) abnormality. We report a case of uterine hyperstimulation accompanied with FHR abnormality caused by the PROPESS in a pregnant woman. Postural change, oxygenation, fluid infusion, and the immediate PROPESS removal were ineffective to address the adverse event, so we administered nitroglycerin for acute uterine relaxation. The nitroglycerin resulted in uterine relaxation, and the FHR abnormality was resolved immediately, thereby preventing an emergency cesarean section. Therefore, nitroglycerin could be considered an effective option for uterine hyperstimulation accompanied with FHR abnormality caused by the PROPESS.

Keywords: cervical ripening; dinoprostone; fetal heart rate abnormality; nitroglycerin; uterine hyperstimulation.

Publication types

  • Case Reports

MeSH terms

  • Cesarean Section
  • Delayed-Action Preparations
  • Dinoprostone*
  • Female
  • Heart Rate, Fetal
  • Humans
  • Labor, Induced
  • Nitroglycerin / therapeutic use
  • Oxytocics* / therapeutic use
  • Pregnancy

Substances

  • Delayed-Action Preparations
  • Oxytocics
  • Nitroglycerin
  • Dinoprostone